Diasorin reported EUR104.36M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Amplifon EUR 445.39M 4.38M Jun/2025
Avanos Medical USD 82.9M 5.2M Jun/2025
Brookdale Senior Living USD 560.24M 28.65M Jun/2025
Cencora USD 77.75B 1.19B Jun/2025
Diasorin EUR 104.36M 4.64M Jun/2025
Encompass Health USD 143M 80.8M Jun/2025
Enovis USD 282.85M 20.47M Jul/2025
GE HealthCare Technologies USD 3.02B 258M Jun/2025
OPKO Health USD 137.75M 38.75M Jun/2025
Zimmer Biomet Holdings USD 752.8M 203M Jun/2025